MedPath

INTERNATIONAL MEDICATION SYSTEMS LIMITED

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

FDA:15

Drug Approvals

Phytonadione

Approval Date
Mar 12, 2024
FDA

Calcium Chloride

Approval Date
Jul 7, 2023
FDA

Regadenoson

Approval Date
Apr 20, 2023
FDA

Epinephrine

Approval Date
Jan 31, 2023
FDA

Lidocaine Hydrochloride

Approval Date
Dec 29, 2022
FDA

Naloxone Hydrochloride

Approval Date
Dec 20, 2022
FDA

Dextrose Monohydrate

Approval Date
Dec 20, 2022
FDA

Sodium Bicarbonate

Approval Date
Dec 15, 2021
FDA

Lidocaine Hydrochloride

Approval Date
Dec 14, 2021
FDA

Naloxone Hydrochloride

Approval Date
Dec 13, 2021
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.